Patients who participated in an intensive lifestyle medicine program before total hip and knee arthroplasty had reduced infection risk and less pain 90 days after surgery compared with those who did ...

The FDA approved a new drug application labeling supplement that allows readministration of iDose TR with a repeat treatment protocol, according to a press release from Glaukos.

Current U.S. Preventive Services Task Force screening guidelines could exclude more than 60% of patients who develop lung cancer.Conversely, an age-based approach to screening could save more than 25, ...

Burdensome health care spending in the United States is a wide-reaching issue that requires multiple solutions, according to ...

A health care tool for an overlooked public health problemFear of needles is one of health care’s most common, and most ignored, barriers.

Abbreviated dual antiplatelet therapy after percutaneous coronary intervention using third-generation stents remained noninferior vs. 12-month DAPT for non-ST-segment elevation myocardial infarction ...

Antidepressant use prior to traumatic brain injury was not associated with worse short-term outcomes for individuals ...

The FDA approved Yuvezzi, an eye drop for the treatment of presbyopia, with broad U.S. availability expected in the second quarter, according to a press release from Tenpoint Therapeutics. Yuvezzi ...

More than one-third of patients with cutaneous chronic graft-versus-host disease had a perception of treatment response that ...

Girls who develop polycystic ovary syndrome and metabolic dysfunction-associated steatotic liver disease as adolescents have increased risk for adverse cardiometabolic outcomes as adults, according to ...

In December, the FDA granted breakthrough status for an implantable kidney replacement system for patients with end-stage kidney disease, according to a company press release.The Holly device by ...

Patients with idiopathic pulmonary fibrosis-associated chronic cough who received twice-daily oral extended release ...